Advisors Asset Management Inc. trimmed its holdings in shares of Alcentra Capital Corp (NASDAQ:ABDC) by 41.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 213,131 shares of the asset manager’s stock after selling 152,140 shares during the period. Advisors Asset Management Inc. owned approximately 1.58% of Alcentra Capital worth $1,362,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Salzhauer Michael boosted its stake in shares of Alcentra Capital by 100.8% in the 2nd quarter. Salzhauer Michael now owns 247,178 shares of the asset manager’s stock worth $910,000 after buying an additional 124,057 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Alcentra Capital by 17.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock worth $4,019,000 after buying an additional 94,111 shares during the last quarter. Finally, Belpointe Asset Management LLC purchased a new position in shares of Alcentra Capital in the 2nd quarter worth $107,000. Institutional investors and hedge funds own 33.59% of the company’s stock.
Separately, ValuEngine downgraded Alcentra Capital from a “hold” rating to a “sell” rating in a research note on Thursday, August 2nd. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. The company has an average rating of “Hold” and an average price target of $7.00.
ABDC stock opened at $5.65 on Thursday. The firm has a market capitalization of $79.01 million, a PE ratio of 4.28 and a beta of 0.59. Alcentra Capital Corp has a 1 year low of $5.58 and a 1 year high of $9.60.
Alcentra Capital (NASDAQ:ABDC) last released its quarterly earnings results on Monday, August 6th. The asset manager reported $0.25 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.20 by $0.05. The firm had revenue of $7.25 million for the quarter, compared to the consensus estimate of $6.82 million. Alcentra Capital had a positive return on equity of 10.10% and a negative net margin of 43.78%. As a group, research analysts predict that Alcentra Capital Corp will post 0.94 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, October 4th. Stockholders of record on Friday, September 28th were paid a $0.18 dividend. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 12.74%. Alcentra Capital’s dividend payout ratio (DPR) is currently 54.55%.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
Further Reading: What are trading strategies for the 52-week high/low?
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.